Bottom line
GNOM vs RYOIX: the short answer
GNOM (Global X Genomics & Biotechnology ETF) and RYOIX (Biotechnology Fund) are quite different portfolios: only about 20% of their top holdings (by weight) are shared.
GNOM is cheaper at 0.5% vs 1.38% — a difference of $88 a year per $10,000 invested.
Over five years, RYOIX returned +4.0% a year vs −13.3% for GNOM.
Updated Nov 19, 2026
GNOM vs RYOIX side by side
| GNOM | RYOIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Global X | Guggenheim |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.5% | 1.38% |
| Annual cost per $10k | $50 | $138 |
| 10-yr cost on $10k (prospectus) | $628 | $1,709 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +19.0% | +30.7% |
| 5-yr return (annualized) | −13.3% | +4.0% |
| 10-yr return (annualized) | — | +5.9% |
| Best quarter | +38.8% | +28.3% |
| Worst quarter | −24.2% | −22.5% |
| Net assets (fund) | $55.8M | $136.8M |
| Number of holdings | 51 | 74 |
| Portfolio turnover | 34% | 75% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GNOM | RYOIX | Difference |
|---|---|---|---|
| 2025 | +19.0% | +30.7% | −11.7% |
| 2024 | −16.2% | −0.7% | −15.4% |
| 2023 | −8.6% | +6.1% | −14.7% |
| 2022 | −36.1% | −13.1% | −23.0% |
| 2021 | −16.0% | +1.8% | −17.8% |
| 2020 | +51.6% | +22.1% | +29.5% |
Source: Fund prospectus bar charts
Holdings overlap
6 of GNOM's top 25 holdings also appear in RYOIX's top 25.
| Holding | GNOM | RYOIX |
|---|---|---|
| Guardant Health, Inc. | 5.59% | 1.72% |
| Illumina, Inc. | 4.82% | 1.94% |
| Natera, Inc. | 4.15% | 2.12% |
| Vertex Pharmaceuticals Incorporated | 3.95% | 4.32% |
| Moderna, Inc. | 3.28% | 2.15% |
| Gilead Sciences, Inc. | 1.95% | 4.49% |
Source: SEC Form N-PORT
GNOM top 10
- Guardant Health, Inc. — 5.59%
- Illumina, Inc. — 4.82%
- Natera, Inc. — 4.15%
- Biomarin Pharmaceutical Inc. — 4.09%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Praxis Precision Medicines Inc — 4.01%
- Twist Bioscience Corp — 3.97%
- Vertex Pharmaceuticals Incorporated — 3.95%
- CRISPR Therapeutics AG — 3.85%
RYOIX top 10
- Abbvie Inc — 8.17%
- Amgen Inc — 5.05%
- Gilead Sciences Inc — 4.49%
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
FAQ
What is the difference between GNOM and RYOIX?
Which is cheaper, GNOM or RYOIX?
Should I own both GNOM and RYOIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.